Related references
Note: Only part of the references are listed.Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease
Louis Chauvelot et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
Sabrina Hoa et al.
RHEUMATOLOGY (2020)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
David Launay et al.
PLOS ONE (2018)
Pulmonary hypertension in systemic sclerosis: different phenotypes
David Launay et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study
Sara R. Schoenfeld et al.
ARTHRITIS CARE & RESEARCH (2016)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis
Motohiro Kimura et al.
RESPIRATION (2013)
Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease Impact of Pulmonary Arterial Hypertension Therapies
Jerome Le Pavec et al.
ARTHRITIS AND RHEUMATISM (2011)
Inaccuracy of Doppler Echocardiographic Estimates of Pulmonary Artery Pressures in Patients With Pulmonary Hypertension Implications for Clinical Practice
Jonathan D. Rich et al.
CHEST (2011)
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
Y. Allanore et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases Impact of Interstitial Lung Disease
Stephen C. Mathai et al.
ARTHRITIS AND RHEUMATISM (2009)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease
Jonathan G. Goldin et al.
CHEST (2008)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
Kunio Hamada et al.
CHEST (2007)
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
U. A. Walker et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Systemic sclerosis: hypothesis-driven treatment strategies
Christina Charles et al.
LANCET (2006)
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
CJ Lettieri et al.
CHEST (2006)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Share Paper
